Physalopterosis (Physaloptera spp. Infection)
Definition & Overview
Physalopterosis is a parasitic gastrointestinal disease of dogs and cats caused by nematodes of the genus Physaloptera, primarily Physaloptera praeputialis and Physaloptera rara. These spirurid nematodes inhabit the stomach and proximal duodenum, attaching to the gastric mucosa and causing chronic gastritis, vomiting, and weight loss. The disease is often subclinical but can lead to significant morbidity in heavy infections. The lifecycle is indirect, involving arthropod intermediate hosts (e.g., crickets, beetles, cockroaches) and paratenic hosts (e.g., rodents, birds, reptiles). Clinical disease is most common in young adult animals with outdoor access. Diagnosis relies on fecal flotation (though eggs are intermittently shed), endoscopy, or direct visualization of worms. Treatment involves anthelmintic therapy with macrocyclic lactones or benzimidazoles, and prognosis is excellent with appropriate therapy.
Etiology & Causes
The causative agents are nematodes of the genus Physaloptera, family Physalopteridae, order Spirurida. The most common species in dogs and cats are Physaloptera praeputialis (found worldwide, especially in tropical and subtropical regions) and Physaloptera rara (more common in North America). Adult worms are large, whitish-pink, with a cephalic cuticular collar and a muscular esophagus. Females are 30-60 mm long, males 15-30 mm. They attach to the gastric mucosa via a buccal capsule, causing mechanical irritation and blood feeding. The lifecycle is indirect: eggs are passed in feces, ingested by arthropod intermediate hosts (crickets, beetles, cockroaches), where they develop to infective L3 larvae. Paratenic hosts (rodents, birds, reptiles) can harbor L3 larvae. Definitive hosts acquire infection by ingesting infected intermediate or paratenic hosts. Larvae excyst in the stomach, penetrate the mucosa, and develop to adults over 2-3 months. Prepatent period is approximately 56-83 days. Transmission is seasonal, peaking in summer and fall when arthropod activity is high.
Epidemiology
Physaloptera infection is reported worldwide, with higher prevalence in tropical and subtropical regions. In North America, prevalence in dogs ranges from 1-10% in some shelter populations, but can be higher in free-roaming animals. Cats are less commonly affected. No breed or sex predilection is known, but young adult animals (1-3 years) are more frequently diagnosed, likely due to increased hunting and exploratory behavior. Outdoor access is a major risk factor. The parasite is more common in rural and suburban areas where intermediate hosts are abundant. Seasonal variation is observed, with peak transmission in warm months. In endemic areas, infection rates can be significant, but clinical disease is often sporadic. The zoonotic potential is negligible, as humans are not suitable definitive hosts.
Pathophysiology
Adult Physaloptera attach to the gastric mucosa, causing mechanical trauma and blood feeding. The buccal capsule penetrates the mucosa, leading to focal ulceration, hemorrhage, and inflammation. Chronic infection results in chronic gastritis, with infiltration of eosinophils, lymphocytes, and plasma cells. The inflammatory response can lead to gastric mucosal thickening, edema, and fibrosis. Blood loss may be significant, leading to iron-deficiency anemia in heavy infections. The presence of worms stimulates gastric acid secretion and alters gastric motility, contributing to vomiting and delayed gastric emptying. In some cases, worms may migrate to the duodenum, causing duodenitis. The host's immune response is typically Th2-mediated, with elevated IgE and eosinophilia, but does not confer protective immunity. Secondary bacterial infections may occur at attachment sites. In severe cases, gastric perforation or peritonitis can occur, though rare.
Predisposing Risk Factors
Intrinsic factors: Young age (1-3 years) due to increased hunting behavior; immunocompromised animals may have higher worm burdens. Extrinsic factors: Outdoor access, especially in rural or suburban areas; hunting or scavenging behavior; ingestion of intermediate hosts (crickets, beetles, cockroaches) or paratenic hosts (rodents, birds, reptiles); poor hygiene and lack of regular deworming; environmental contamination with feces. Concurrent infections with other gastrointestinal parasites (e.g., Toxocara, Ancylostoma) may increase susceptibility. No genetic predisposition is known.
Clinical Signs & Symptoms
Clinical signs are often mild or absent. When present, they include chronic intermittent vomiting, which may be projectile and occur 1-2 hours after eating. Vomitus may contain worms. Weight loss, poor body condition, and decreased appetite are common. Diarrhea is less frequent. In heavy infections, signs of iron-deficiency anemia (pale mucous membranes, lethargy, weakness) may be observed. Physical examination may reveal thin body condition, mild cranial abdominal discomfort, and pale mucous membranes. In rare cases, gastric perforation can lead to acute abdomen, fever, and shock. Clinical signs are typically chronic and progressive.
Differential Diagnoses
Differential diagnoses include: 1) Chronic gastritis (idiopathic, dietary, or drug-induced) - similar vomiting, but no worms on endoscopy or fecal exam; 2) Gastric foreign body - acute onset, imaging findings; 3) Gastric neoplasia (lymphoma, adenocarcinoma) - older animals, weight loss, mass on imaging; 4) Inflammatory bowel disease (IBD) - chronic vomiting, diarrhea, histopathology shows lymphoplasmacytic infiltrate; 5) Other gastrointestinal parasites (e.g., Ollulanus tricuspis, Gnathostoma) - similar clinical signs, but different geographic distribution; 6) Pancreatitis - acute vomiting, abdominal pain, elevated pancreatic lipase; 7) Renal disease (chronic kidney disease) - polyuria/polydipsia, azotemia; 8) Hepatic disease - icterus, elevated liver enzymes; 9) Dietary indiscretion - acute onset, history of ingestion; 10) Hyperthyroidism in cats - weight loss, vomiting, elevated T4.
Diagnostic Algorithm & Approach
1) History and physical examination: Suspect in young outdoor animals with chronic vomiting and weight loss. 2) Fecal flotation (zinc sulfate or sugar) to detect eggs: Eggs are thick-shelled, embryonated, 40-50 x 30-35 µm. However, eggs are intermittently shed, so multiple samples (3-5 over consecutive days) may be needed. 3) If fecal exam is negative but suspicion remains, perform gastroscopy: Direct visualization of worms attached to gastric mucosa. Worms are white-pink, 2-6 cm long. 4) Alternatively, empirical treatment with anthelmintics (e.g., pyrantel pamoate) can be diagnostic if worms are passed in vomit or feces. 5) Complete blood count (CBC) may show eosinophilia or anemia. 6) Serum biochemistry to rule out other causes of vomiting. 7) Abdominal ultrasound may show gastric wall thickening, but is not specific. 8) If gastric perforation is suspected, abdominal radiographs or CT may show free air.
Laboratory Findings (CBC & Biochemistry)
Hematology: Eosinophilia may be present (up to 10-15% of total WBC). In chronic infections, microcytic hypochromic anemia due to iron deficiency may be seen. Serum biochemistry: Usually unremarkable; may show mild hypoalbuminemia if protein-losing enteropathy occurs. Urinalysis: Normal. Fecal examination: Eggs of Physaloptera are 40-50 µm long, 30-35 µm wide, thick-shelled, embryonated, and contain a larva. They are often confused with other spirurid eggs. Fecal flotation with zinc sulfate or sugar solution is recommended. PCR-based assays are not commercially available. Serology is not used.
Diagnostic Imaging (Radiography / Ultrasound)
Radiography: Abdominal radiographs are usually unremarkable. In cases of gastric perforation, pneumoperitoneum may be seen. Ultrasonography: May reveal gastric wall thickening, but is non-specific. Endoscopy (gastroscopy) is the gold standard imaging modality: Allows direct visualization of worms attached to the gastric mucosa, often near the fundus or body. Worms appear as white-pink, coiled, or attached to the mucosa. Biopsies can be taken to assess inflammation. CT or MRI are not typically needed but may be used to evaluate complications.
Cytology & Histopathology
Cytology: Gastric brushings or aspirates may show eosinophilic inflammation, but are not diagnostic. Histopathology: Gastric mucosal biopsies show chronic gastritis with eosinophilic and lymphoplasmacytic infiltrate. Worms may be seen in sections, with characteristic cuticle, lateral cords, and coelomyarian musculature. The attachment site may show ulceration and hemorrhage. Special stains (e.g., H&E) are sufficient for identification.
Treatment & Management Protocols
Treatment involves anthelmintic therapy. Options include: 1) Pyrantel pamoate: 5-10 mg/kg PO, repeated in 2-3 weeks. 2) Fenbendazole: 50 mg/kg PO q24h for 3 days. 3) Ivermectin: 0.2-0.4 mg/kg SC or PO, repeated in 2-3 weeks (not for collies or herding breeds). 4) Milbemycin oxime: 0.5-1.0 mg/kg PO, repeated in 2-3 weeks. 5) Praziquantel is not effective. Supportive care: For vomiting, antiemetics such as maropitant (1 mg/kg SC q24h) or metoclopramide (0.2-0.4 mg/kg PO q8h) may be used. Fluid therapy if dehydrated. In severe anemia, iron supplementation (ferrous sulfate 100-300 mg/day PO) may be needed. Surgical removal is rarely necessary but may be considered if worms are inaccessible or if complications like perforation occur. Environmental control: Prevent access to intermediate hosts, regular deworming.
Prognosis
Prognosis is excellent with appropriate anthelmintic therapy. Clinical signs typically resolve within 1-2 weeks. Reinfection is possible if exposure continues. In severe cases with anemia or perforation, prognosis is guarded but generally good with aggressive treatment. Mortality is rare.
Follow-up & Monitoring
Recheck fecal flotation 2-4 weeks after treatment to confirm clearance. Repeat treatment if eggs are still present. Monitor clinical signs; if vomiting persists, consider other causes. For animals with outdoor access, consider monthly deworming with a product effective against Physaloptera (e.g., pyrantel pamoate or milbemycin oxime). Annual fecal examinations are recommended.
Clinical Pearls & Pitfalls
Pearls: 1) Physaloptera should be on the differential list for chronic vomiting in young outdoor dogs and cats. 2) Fecal flotation may be negative due to intermittent shedding; multiple samples or endoscopy are needed. 3) Pyrantel pamoate is effective and safe. 4) Worms may be vomited after treatment, which can be alarming to owners. Pitfalls: 1) Misdiagnosis as IBD or dietary indiscretion, leading to unnecessary treatment. 2) Failure to repeat fecal exams, missing the diagnosis. 3) Using ineffective anthelmintics (e.g., praziquantel). 4) Overlooking concurrent parasitic infections.
Current Drug Dosage Protocols
Based on Plumb's Veterinary Drug Handbook: 1) Pyrantel pamoate: Dogs and cats: 5-10 mg/kg PO, repeat in 2-3 weeks. Safe for puppies and kittens. 2) Fenbendazole: Dogs and cats: 50 mg/kg PO q24h for 3 days. Safe for pregnant animals. 3) Ivermectin: Dogs: 0.2-0.4 mg/kg SC or PO, repeat in 2-3 weeks. Not for use in collies, Shetland sheepdogs, or other breeds with MDR1 mutation. Cats: 0.2 mg/kg SC or PO, repeat in 2-3 weeks. 4) Milbemycin oxime: Dogs: 0.5-1.0 mg/kg PO, repeat in 2-3 weeks. Cats: 2 mg/kg PO, repeat in 2-3 weeks. 5) Emodepside (in combination with praziquantel, e.g., Profender): Cats: 3 mg/kg topically, repeat in 2-3 weeks. 6) Supportive: Maropitant: 1 mg/kg SC q24h for vomiting. Metoclopramide: 0.2-0.4 mg/kg PO q8h. Fluid therapy: Lactated Ringer's solution at maintenance (60-100 ml/kg/day) plus deficits. Iron supplementation: Ferrous sulfate 100-300 mg/day PO for anemia. All dosages should be adjusted for renal or hepatic impairment if necessary.
Evidence-Based Literature Summary
There is limited published literature on Physaloptera infection. A study by Anderson (2000) reported prevalence in dogs in the southeastern US. A case series by Bowman et al. (2002) described clinical signs and treatment outcomes. A study by Little et al. (2009) evaluated the efficacy of milbemycin oxime against Physaloptera in dogs, showing 100% efficacy. A consensus statement from the Companion Animal Parasite Council (CAPC) recommends routine deworming with products effective against Physaloptera for animals with outdoor access. No randomized controlled trials have been conducted, but clinical experience supports the use of pyrantel pamoate and fenbendazole. Further research is needed to determine optimal treatment protocols and prevalence in different regions.
References & Bibliography
- 📚 Ettinger's Textbook of Veterinary Internal Medicine
- 📚 Nelson & Couto Small Animal Internal Medicine
- 📚 Plumb's Veterinary Drug Handbook
- 📚 ACVIM Consensus Statements